16:54 EST Xeris Biopharma (XERS) files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XERS:
- Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
- Xeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
- XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Xeris Pharmaceuticals Appoints New Chief Medical Officer
- Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed
Questions or Comments about the article? Write to editor@tipranks.com